Researchers at University of Exeter in the UK exposed E coli bacteria to eight rounds of antibiotic treatment.
They found that mutated E coli reproduced faster than before encountering the drugs and formed populations that were three times larger because of the mutations.
This was only seen in bacteria exposed to antibiotics - and when researchers took the drug away, the evolutionary changes were not undone and the new-found abilities remained.
"Bacteria have a remarkable ability to rearrange their DNA and this can stop drugs working, sometimes in a matter of days," said Beardmore.
"While rapid DNA change can be dangerous to a human cell, to a bacterium like E coli it can have multiple benefits, provided they hit on the right changes," he added.
The researchers tested the effects of the antibiotic doxycycline on E coli as part of a study of DNA changes brought about by antibiotics.
Some changes are well known and have been seen in clinical patients, like E coli producing more antibiotic pumps that bacteria exploit to push antibiotics out of the cell.
Another change saw the loss of DNA that is known to describe a dormant virus.
"Our best guess is that losing viral DNA stops the E coli destroying itself, so we see more bacterial cells growing once the increase in pump DNA allows them to resist the antibiotic in the first place," said Carlos Reding, from University of Exeter.
"Normally, self-destruction can help bacteria colonise surfaces through the production of biofilms. You see biofilms in a dirty sink when you look down the plughole," he said.
"But our study used liquid conditions, a bit like the bloodstream, so the E coli could give up on its biofilm lifestyle in favour of increasing cell production," he added.
"It is said by some that drug resistance evolution doesn't take place at high dosages but our paper shows that it can and that bacteria can change in ways that would not be beneficial for the treatment of certain types of infection," said Mark Hewlett of the University of Exeter.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
